Coronavirus: Merck says deal with Singapore signed; South Korea soon to inoculate pregnant women
Published
Oct 06 2021 at 6:34 AM GMT
Key
Points
Points
- Merck on Wednesday announced it had entered into an agreement with Singapore to provide molnupiravir, an investigational antiviral drug to treat Covid-19, once it is authorised or approved.
- Molnupiravir is designed to introduce errors into the genetic code of the virus and would be the first oral antiviral medication for Covid-19.
- Merck is seeking approval by the US Food and Drug Administration for the pill.
- Singapore’s health ministry did not immediately respond to a request for confirmation of….
Trending
Stats
- Published Oct 6, 2021 6:34 AM GMT